Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Diglycerol)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003032 AN004971 Effects of Preanalytical Sample Collection and Handling on Comprehensive Metabolite Measurements in Human Urine Biospecimens Urine Human National Center for Advancing Translational Sciences Other
ST002820 AN004594 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) Blood Human Tufts Medical Center Other
ST002819 AN004590 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) Blood Human Tufts Medical Center Other
ST002803 AN004559 Early life metabolic abnormalities in the bone marrow of the offspring of obese mothers Bone marrow Mouse Metabolic syndrome Oregon Health and Science University GC-MS
ST002155 AN003530 Longitudinal metabolomic stool dynamics in primary C. difficile infections Feces Human Bacterial infection Brigham and Women's Hospital LC-MS
ST002020 AN003290 TIPs Metabolomics (urine) Urine Human Vanderbilt University Medical Center LC-MS
ST002018 AN003288 Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) Feces Human Vanderbilt University Medical Center LC-MS
ST001940 AN003155 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001940 AN003156 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001940 AN003157 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001940 AN003158 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles LC-MS
ST001937 AN003150 Comprehensive plasma metabolomics and lipidomics based management of benign and malignant solitary pulmonary nodules Blood Human Cancer China Pharmaceutical University GC-MS/LC-MS
ST001929 AN003137 Metabolomics profiles of premenopausal women are different based on O-desmethylangolensin metabotype (Part 2) Urine Human George Mason University GC-MS
ST001901 AN003092 Mitochondrial-Derived Compartments Facilitate Cellular Adaptation to Amino Acid Stress Yeast cells Yeast University of Utah School of Medicine GC-MS
ST001835 AN002977 Use of Integrated Metabolomics, Transcriptomics, and Signal Protein Profile to Characterize the Effector Function and Associated Metabotype of Polarized Macrophage Phenotypes Blood Human Idaho Veterans Research and Education Foundation LC-MS
ST001827 AN002963 The pregnancy metabolome from a multi-ethnic pregnancy cohort Blood Human Icahn School of Medicine at Mount Sinai LC-MS
ST001700 AN002771 A cross-sectional study of functional and metabolic changes during aging through the lifespan in male mice (Serum) part-II Blood Mouse National Institutes of Health GC-MS
ST001650 AN002696 Changes to gut microbiota metabolism based on Clostridium difficile-induced inflammation Feces Mouse Infection Stanford University GC-MS
ST001495 AN002478 Effects of Synbiotic Administration on Fecal Microbiome and Metabolomic Profiles of Dogs receiving Antibiotics Feces Dog University of California, Davis GC-MS
ST001404 AN002346 Ontogeny related changes in the pediatric liver metabolome (part-III) Liver Human Moffitt Cancer Center LC-MS
ST001403 AN002345 Ontogeny related changes in the pediatric liver metabolome (part-II) Liver Human Moffitt Cancer Center LC-MS
ST000981 AN001607 Metabolomic profiles in healthy research cats receiving clindamycin with a synbiotic or a placebo: a randomized, controlled trial (Part II) Feces Cat Antibiotic resistance University of California, Davis GC-MS
ST000979 AN001603 Metabolomic profiles in healthy research cats receiving clindamycin with a synbiotic or a placebo: a randomized, controlled trial Feces Cat Antibiotic resistance University of California, Davis GC-MS
ST000969 AN001583 Impact of thiamine metabolites and spent medium from Chlorella sorokiniana on metabolism in the green algae Auxenochlorella prototheciodes (part II) Cultured cells Auxenochlorella University of California, Davis GC-MS
ST000884 AN001441 Evidence that COG0325 proteins are involved in PLP homeostasis Cells E. coli University of California, Davis GC-MS
ST000865 AN001390 Identification of Race-Associated Metabolite Biomarkers for Hepatocellular Carcinoma Blood Human Cancer Georgetown University GC-MS
ST000392 AN000628 Systemic Metabolomic Changes in Blood Samples of Lung Cancer Patients Identified by Gas Chromatography Time-of-Flight Mass Spectrometry Blood Human Cancer University of California, Davis GC-MS
ST000087 AN000139 A study of changes in lipid metabolism of ovarian cancer cells co-cultured with adipocytes: GC-TOF MS analysis Unspecified Human Cancer University of California, Davis GC-MS
ST000048 AN000084 Metabolomic & lipidomic profiles in response to exogenous insulin & GLP-1 infusions during prolonged fasting (GCMS) Blood Seal Diabetes University of California, Davis GC-MS
  logo